On the morning of October 30th, Jiang Jufang, Executive President of Zhejiang Pharmaceutical Industry Association, accompanied by Chi Zongliang and Huang Jie, Deputy Secretaries-General of the Association, paid a research and guidance visit to Benefit Pharmaceutical. Yan Lianhe, Secretary-General of Lishui Pharmaceutical and Health Industry Association, and Yan Haibo, General Manager of Lishui Int Pharmaceutical Co., Ltd., accompanied the visit. Zhang Liyun, Executive President of Benefit Pharmaceutical, together with Zhu Yini, Vice President of Quality, Hu Lizhen, Director of Administration, Chen Xia, Director of Project Department, and Che Xin, Secretary to the Chairman, received the visiting group.

Hu Lizhen, Director of Administration, introduced to the leaders the company's four core sectors, namely industry, commerce, agricultural planting, and traditional Chinese medicine (TCM) medical services, as well as its core products and future development plans for the industry.

President Jiang and his entourage conducted an on - site inspection of the logistics and warehousing center. Zhang Liyun, Executive President, exchanged views with the association leaders on the current filing status of the enterprise's TCM formula granules in accordance with provincial and national standards, as well as the production technology and product convenience of TCM formula granules. A key introduction was made to the product "Tetrastigma hemsleyanum Powder (Zhejiang - produced)", a new member of the "New Eight Flavors of Zhejiang". The exchange focused on the construction of standardized base planting, clinical application effects, and sales channels.

During the forum, President Jiang stated that the purpose of this research is to listen to the demands and difficulties encountered by enterprises in the process of development, so as to provide more targeted support policies. Zhang Liyun, Executive President, first introduced the current industrial planning of Lishui City. The TCM big health industry is an important part of the "5 + 5" modern industrial cluster in Lishui's modern economic system, with "Ganoderma lucidum, Tetrastigma hemsleyanum (Zhejiang - produced), Polygonatum sibiricum, and Dendrobium" as the four key promoted gold products in Lishui. Benefit Pharmaceutical will focus on Tetrastigma hemsleyanum (Zhejiang - produced) and build a billion - yuan product through the model of promoting the primary industry and the tertiary industry with the secondary industry. In - depth discussions were also held on issues such as how to include large - scale products in the medical insurance co - ordination and the instability of raw material prices. It is hoped that the Zhejiang Pharmaceutical Industry Association will use its platform advantages to effectively remove the obstacles in the industrial development of enterprises and help pharmaceutical enterprises achieve high - quality development.